Harvard Apparatus Regenerative Technology amends 8-K; discloses $300K bridge note from CEO

Harvard Apparatus Regenerative Technology, Inc.

Amendment corrects prior 8-K: loan from CEO Junli He was a new agreement, not a termination.
Bridge Note: $300,000 principal, 8% fixed interest, due April 13, 2027 or upon $5M capital raise.
Optional conversion at lender's discretion; includes customary covenants and events of default.
Loan provided by Chairman and CEO Junli He.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.